Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

More On MBI.V

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Med Biogene Inc (MBI.V)

-TSXV
0.08 Down 0.01(6.25%) Apr 17, 3:59PM EDT
Add to Portfolio
Prev Close:0.08
Open:0.08
Bid:0.08
Ask:0.08
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.08 - 0.08
52wk Range:0.03 - 0.11
Volume:1,233
Avg Vol (3m):103,403
Market Cap:6.29M
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Med BioGene Inc., a life science company, focuses on managing the license and rights to the genomic-based clinical laboratory diagnostic tests. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback